share_log

东兴证券股份有限公司关于中源协和细胞基因工程股份有限公司2023年度募集资金存放与使用情况的专项核查意见

Dongxing Securities Co., Ltd.'s special inspection opinion on the storage and use of funds raised by Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd. in 2023

Sensex a share ·  Apr 25
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more